Simplex Trading’s PhenomeX Inc. Common Stock CELL Stock Holding History

Simplex Trading’s Portfolio CELL Stock Details CELL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-2,100	Closed	-$3K	–	10273
2023 Q3	$3K	Buy	+2,100	New	+$1.61K	﹤0.01%	8015
2023 Q1	–	Sell	-1,400	Closed	-$3K	–	10518
2022 Q4	$3K	Sell	1,400 -10,600	-88%	-$27.9K	﹤0.01%	8479
2022 Q3	$34K	Buy	12,000 +9,800	+445%	+$41.7K	﹤0.01%	6941
2022 Q2	$10K	Sell	2,200 -4,000	-65%	-$21K	﹤0.01%	8337
2022 Q1	$44K	Buy	6,200 +500	+9%	+$4.14K	﹤0.01%	7328
2021 Q4	$103K	Buy	5,700 +4,900	+613%	+$106K	﹤0.01%	6211
2021 Q3	$37K	Buy	800 +200	+33%	+$7.61K	﹤0.01%	7896
2021 Q2	$26K	Buy	600 +545	+991%	+$25.3K	﹤0.01%	8357
2021 Q1	$276K	Buy	55 +6	+12%	+$409	﹤0.01%	4250
2020 Q4	$438K	Buy	+49	New	+$4.12K	﹤0.01%	3605

Simplex Trading's CELL Position: Q4 2022 in Review

Simplex Trading sold out of PhenomeX Inc. Common Stock (CELL) in Q4 2022, closing a stake of 5,823 shares — an estimated $15.3K sold.

Simplex Trading first reported a position in CELL in Q4 2021 and held it in 4 quarters. The position peaked at $121K in Q2 2022. 117 funds tracked by Wall St. Rank hold CELL as of Q4 2022.

Simplex Trading reported no remaining PhenomeX Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Simplex Trading sold 5,823 PhenomeX Inc. Common Stock shares in Q4 2022, an estimated $15.3K.
Simplex Trading first reported a position in PhenomeX Inc. Common Stock in Q4 2021 and held it in 4 quarters.
Simplex Trading's PhenomeX Inc. Common Stock position peaked at $121K in Q2 2022.
117 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q4 2022.

Based on Simplex Trading's 13F filing for Q4 2022, filed 2 Feb 2023.